User profiles for Katherine Zukotynski
 | Katherine ZukotynskiProfessor, McMaster University Verified email at utoronto.ca Cited by 3737 |
[HTML][HTML] Imatinib for melanomas harboring mutationally activated or amplified KIT arising on mucosal, acral, and chronically sun-damaged skin
…, MC Heinrich, C Beadling, KA Zukotynski… - Journal of clinical …, 2013 - ncbi.nlm.nih.gov
… Zukotynski, Annick D. Van den Abbeele, George D. Demetri, David E. … Zukotynski,
Jeffrey T. Yap, Annick D. Van den Abbeele … Zukotynski, Jeffrey T. Yap, Annick D. Van den …
Jeffrey T. Yap, Annick D. Van den Abbeele … Zukotynski, Jeffrey T. Yap, Annick D. Van den …
[HTML][HTML] Pheochromocytoma and paraganglioma: imaging characteristics
The accurate diagnosis of adult pheochromocytoma and paraganglioma necessitates a
multidisciplinary approach that includes clinical history, biochemical testing, and multimodality …
multidisciplinary approach that includes clinical history, biochemical testing, and multimodality …
[HTML][HTML] Diagnostic performance and safety of positron emission tomography with 18F-rhPSMA-7.3 in patients with newly diagnosed unfavourable intermediate-to very …
…, E Uchio, GA Ulaner, JM Wixom, D Yoo, K Zukotynski - European urology, 2023 - Elsevier
Background Radiohybrid (rh) 18 F-rhPSMA-7.3 is a novel high-affinity prostate-specific
membrane antigen (PSMA)-targeting radiopharmaceutical for prostate cancer (PCa) imaging. …
membrane antigen (PSMA)-targeting radiopharmaceutical for prostate cancer (PCa) imaging. …
Pneumatosis intestinalis and bowel perforation associated with molecular targeted therapy: an emerging problem and the role of radiologists in its management
…, KM Krajewski, KA Zukotynski… - American Journal of …, 2012 - Am Roentgen Ray Soc
OBJECTIVE. The purpose of this article is to study the imaging features, management, and
outcome of pneumatosis intestinalis and bowel perforation associated with molecular …
outcome of pneumatosis intestinalis and bowel perforation associated with molecular …
Appropriate use criteria for 18F-FDG PET/CT in restaging and treatment response assessment of malignant disease
…, RM Subramaniam, K Zukotynski… - Journal of Nuclear …, 2017 - Soc Nuclear Med
Precision medicine is evolving to include a variety of data to optimize patient care and
improve outcome. Multimodality imaging is paving the way toward this goal. PET/CT with 18 F-…
improve outcome. Multimodality imaging is paving the way toward this goal. PET/CT with 18 F-…
Contrast echocardiography grading predicts pulmonary arteriovenous malformations on CT
K Zukotynski, RP Chan, CM Chow, JH Cohen… - Chest, 2007 - Elsevier
Background: Untreated pulmonary arteriovenous malformations (PAVMs) can present with
life-threatening complications. Agitated saline solution transthoracic contrast …
life-threatening complications. Agitated saline solution transthoracic contrast …
A radiology-focused review of predictive uncertainty for AI interpretability in computer-assisted segmentation
B McCrindle, K Zukotynski, TE Doyle… - Radiology: Artificial …, 2021 - pubs.rsna.org
The recent advances and availability of computer hardware, software tools, and massive
digital data archives have enabled the rapid development of artificial intelligence (AI) …
digital data archives have enabled the rapid development of artificial intelligence (AI) …
Targeted radionuclide therapy: practical applications and future prospects: supplementary issue: biomarkers and their essential role in the development of …
In recent years, there has been a proliferation in the development of targeted radionuclide
cancer therapy. It is now possible to use baseline clinical and imaging assessments to …
cancer therapy. It is now possible to use baseline clinical and imaging assessments to …
Somatostatin receptor imaging and theranostics: current practice and future prospects
…, C Millo, K Prasad, D Wilson, K Zukotynski… - Journal of Nuclear …, 2021 - Soc Nuclear Med
A new era of precision diagnostics and therapy for patients with neuroendocrine neoplasms
began with the approval of somatostatin receptor (SSTR) radiopharmaceuticals for PET …
began with the approval of somatostatin receptor (SSTR) radiopharmaceuticals for PET …
Imaging of liposarcoma: classification, patterns of tumor recurrence, and response to treatment
…, K Krajewski, K Zukotynski… - American Journal of …, 2011 - Am Roentgen Ray Soc
OBJECTIVE. The purpose of this study was to illustrate the subtypes of liposarcoma (LPS)
and the significance of the nonlipomatous tumor components using multiple imaging …
and the significance of the nonlipomatous tumor components using multiple imaging …